Compounds > ruthenium
Page last updated: 2024-08-22

ruthenium and Carcinoma, Lewis Lung

ruthenium has been researched along with Carcinoma, Lewis Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Gui, L; Li, Y; Liu, J; Lu, Y; Wang, W; Wang, Y; Zhu, D1
Alessio, E; Bergamo, A; Cocchietto, M; Gava, B; Mestroni, G; Sava, G; Serli, B; Zorzet, S1
Bergamo, A; Cocchietto, M; DiGiovine, S; Garbisa, S; Pezzoni, G; Sartor, L; Sava, G; Soranzo, M; Turrin, C; Vita, F; Zabucchi, G; Zorzet, S1
Cocchietto, M; Sava, G; Sorc, A; Zorzet, S1
Alessio, E; Capozzi, I; Clerici, K; Cocchietto, M; Gagliardi, R; Mestroni, G; Perbellini, A; Sava, G1

Other Studies

5 other study(ies) available for ruthenium and Carcinoma, Lewis Lung

ArticleYear
A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway.
    Journal of nanobiotechnology, 2021, Apr-23, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanomedicine; Poly(ADP-ribose) Polymerase Inhibitors; Receptors, Transferrin; Ruthenium; Transferrin

2021
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
    International journal of oncology, 2002, Volume: 21, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; G2 Phase; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mitosis; Neoplasm Invasiveness; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured

2002
Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Adhesion; Cell Division; Collagen; Collagen Type IV; Dimethyl Sulfoxide; Drug Combinations; Female; Humans; Kidney; Laminin; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Invasiveness; Organometallic Compounds; Proteoglycans; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured

2003
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
    Investigational new drugs, 2003, Volume: 21, Issue:1

    Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; Disease Models, Animal; Female; Injections, Intraperitoneal; Kidney; Liver; Lung; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Species Specificity

2003
Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.
    Anti-cancer drugs, 1999, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Lewis Lung; Cell Cycle; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred Strains; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Spectrophotometry, Atomic; Tissue Distribution

1999